-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the 24th, Qianjin Pharmaceutical announced that its subsidiary Qianjin Xiangjiang Pharmaceutical received the "Drug Registration Certificate" for valsartan tablets approved by the State Food and Drug Administration.
Valsartan tablets are an angiotensin II receptor blocker developed by Novartis, Switzerland, and are mainly used for mild to moderate essential hypertension
Up to now, the company has invested approximately RMB 10.